Rimoni 2025: The industrial core is holding up, but the dividend is already stretching the cash cushion

Company Overview

At first glance, Rimoni looks like a small, old-economy manufacturer: plastics, molds, two Israeli plants, some overseas activity, and no bank debt. That is only a partial read. The real economics of the business sit almost entirely in plastics, which generated 93% of external revenue and 98% of segment profit in 2025. The molds segment matters as an entry layer, an engineering layer, and part of the end-to-end proposition, but it is not the real profit engine. That is why a reader who stops at the clean balance sheet or the annual net profit misses the main point: Rimoni is operationally better than the headline earnings decline suggests, but financially less relaxed than the consolidated balance sheet alone implies.

What is working is clear enough. The plastics segment still produced NIS 39.2 million of segment profit in 2025, group operating profit remained high in absolute terms at NIS 40.3 million, and the company ended the year with NIS 14.1 million of cash and cash equivalents and no bank loans. Even during the June 2025 security disruption, and even after a direct hit to a major raw-material supplier's production site, the company kept production running through inventory buffers, immediate purchases, and alternative sourcing in Europe. That is not trivial.

What is still not clean is also clear. Revenue was roughly flat, but profitability weakened, net profit fell 16.8%, revenue outside Israel fell 8.9%, auto-related activity softened, and the fourth quarter closed with only NIS 5.0 million of net profit versus NIS 8.4 million in the third quarter. The key issue is not leverage or covenant pressure. It is the quality of the cushion: the business still generates solid operating cash, but the distribution policy is running ahead of the cash left after all actual uses of cash. That is now a question of shareholder-accessible value, not just accounting value creation.

In other words, Rimoni enters 2026 as a real industrial business with a credible operating base, but with a clear screen: for the read to improve, exports and auto need to stabilize, the newer growth pockets need to become more meaningful, and the payout pace needs to leave more cash inside the system. Until that happens, this remains a profitable company, but not one with a wide margin for error.

The quick economic map looks like this:

Events And Triggers

What changed in the operating mix

The first trigger: the slowdown did not hit everything equally. It hit the side of the business that is more exposed to exports, currency, and auto. Total revenue fell only 0.6%, but revenue outside Israel fell 8.9%, and auto sales within the plastics business dropped from NIS 42.4 million to NIS 35.9 million. At the same time, domestic revenue rose to NIS 139.9 million, and irrigation, water, and agriculture remained the largest end-market in plastics at NIS 38.7 million. That matters, because it says the business did not break, but the mix moved against it.

The second trigger: management is framing defense as a growth engine, and it did grow in 2025, but the scale still needs perspective. Sales in that vertical rose from NIS 3.0 million to NIS 4.2 million. Relative growth was strong. In absolute terms, it is still just 2% of group revenue. So it is an important directional signal, but not yet large enough to offset prolonged weakness in auto or exports on its own.

The third trigger: the 2025 security events did not materially damage results, but they did expose what can actually get stuck. During the June 2025 operation, the production site of a major raw-material supplier was directly hit. Rimoni bridged that disruption through immediate purchases, alternative European suppliers, and 2 to 3 weeks of safety inventory. That shows solid operating execution, but it also shows that the supply chain is less generic than a superficial read would suggest.

The fourth trigger: after year-end, on March 25, 2026, the board declared another cash dividend of about NIS 10.1 million. Around the same period, the company also announced that Gad and Rafi Rimoni would cut their employment scope to 25% from February 2026 as part of a management refresh. These are different kinds of events, but together they point to the two near-term lenses through which the market is likely to read Rimoni: capital allocation discipline and management transition.

Efficiency, Profitability, And Competition

The key point is that the core remained profitable, but margins no longer had the same tailwind. Revenue in 2025 came in at NIS 181.8 million versus NIS 183.0 million in 2024, gross profit fell to NIS 54.6 million from NIS 56.0 million, and gross margin edged down from 30.6% to 30.0%. That is not a collapse, but it is real erosion. Operating profit fell from NIS 43.2 million to NIS 40.3 million. Net profit fell more sharply, from NIS 41.3 million to NIS 34.3 million, largely because financing moved from net income of NIS 2.8 million in 2024 to net expense of NIS 1.5 million in 2025.

Management itself ties this to two core drivers: a stronger shekel against the dollar and the euro, and lower activity with European auto customers. This is exactly where it is important not to stop at the flat revenue headline. When overseas activity weakens and FX moves against you, stable total revenue can hide weaker economic quality. What saved the year was redistribution inside the mix: more domestic activity, a sharp jump in the technical segment, growth in defense, and relatively steady medical activity.

Plastics still carry the group

In 2025, plastics generated NIS 169.1 million of external revenue and NIS 39.2 million of segment profit. Molds generated only NIS 12.8 million of external revenue and NIS 0.8 million of segment profit. That is important because molds can easily be over-read as a second engine. In practice they are more of a customer entry point, an engineering layer, and part of the one-stop-shop offering. In 2024 the molds segment actually posted a NIS 2.5 million segment loss, so the move back to a small profit in 2025 is helpful, but it does not change where the real economics sit.

What really supports plastics is not necessarily stronger pricing. It is the breadth of the proposition: product design, engineering, prototyping, mold work, component manufacturing, and assemblies. This is not a monopoly and not an untouchable moat. The company itself describes the plastics market as highly competitive, with many Israeli manufacturers and foreign competition, especially in labor-intensive products. But the combination of engineering, molds, real-time maintenance, and the ability to manage complex projects still gives Rimoni practical edge with customers who are not choosing solely on price.

Competition is real, but there is still room to move

Two capacity data points matter here. In molds, the company estimates that it is using about 50% of its domestic potential capacity. In plastics, the Modiin and Kiryat Shmona plants are running at roughly 70% average utilization, with labor availability named as the constraint. That means Rimoni's current issue is not missing machines or missing floor space. It is the ability to fill the system with profitable demand and the workforce needed to support it. That is positive, because there is room to grow without a major balance-sheet move. It is also limiting, because spare capacity does not create value by itself if the demand mix continues to weaken.

The fourth quarter makes that point especially well. Revenue fell to NIS 41.5 million from NIS 47.5 million in Q3, and net profit fell to NIS 5.0 million from NIS 8.4 million. That does not automatically mean a structural break, but it is a clear sign that the second half of the year was weaker in quality than the full-year totals alone suggest.

Cash Flow, Debt, And Capital Structure

The consolidated balance sheet still looks clean

At the consolidated level, Rimoni looks very orderly. At year-end it had NIS 14.1 million of cash and cash equivalents, NIS 170.0 million of equity, and no bank loans. Financial liabilities are mostly payables and lease liabilities, with lease obligations totaling only about NIS 2.3 million. Management also explicitly states that the company had no loans at the report date, which is why higher rates were not a material factor in 2025 results. If you stop there, the picture looks comfortable.

But this is where it is important not to confuse a clean balance sheet with wide cash flexibility. No bank debt is not the same thing as a large capital-allocation cushion, especially when the dividend runs ahead of annual earnings.

In all-in cash flexibility terms, the picture is already tighter

To understand what is really left, it helps to separate two cash lenses. On a normalized / maintenance cash generation basis, meaning how much cash the business produces before discretionary uses, Rimoni still looks good: operating cash flow was NIS 43.2 million, reported CAPEX was NIS 1.7 million, and lease principal repayment was NIS 1.1 million. That leaves about NIS 40.3 million of recurring cash generation before dividends.

But on an all-in cash flexibility basis, meaning how much remains after actual cash uses, the story changes. The dividend paid in 2025 was NIS 45.5 million, above annual net profit. After NIS 1.9 million of investing outflow and NIS 46.4 million of financing outflow, year-end cash fell by NIS 5.1 million, from NIS 21.5 million to NIS 14.1 million. So the business did generate cash, but shareholders received more than what was left after the real uses of cash.

The real 2025 cash picture looks like this:

At the parent level, the cushion is even thinner

This is where the less obvious insight sits. In the solo statements, the parent company ended 2025 with only NIS 1.37 million of cash. During the year it received NIS 42.4 million of dividends from subsidiaries and paid NIS 45.5 million to shareholders. In other words, shareholder access to value does not come from idle parent-level liquidity. It comes from the ability to keep moving cash up from the operating subsidiaries. That is a meaningful gap between value created inside the group and value that is immediately accessible to listed-company shareholders.

This is not a classic liquidity problem, because the group is not bank-levered. But it does mean the core question has already shifted from "does the company have debt?" to "how much real cushion is left after distribution?" The March 2026 dividend of about NIS 10.1 million only sharpens that question.

Outlook

Before going into the details, it is worth stating four non-obvious findings clearly:

• First finding: 2026 looks more like a bridge year than a breakout year. The business is not fragile, but it is not entering the year with broad tailwinds either.
• Second finding: the issue is not lack of balance-sheet capacity or lack of equipment. It is whether demand mix improves and labor allows the company to use the available capacity more effectively.
• Third finding: defense matters as direction, but it is still too small to offset a prolonged drag from auto and exports on its own.
• Fourth finding: the dividend policy has moved from a separate capital-allocation topic into the core operating thesis, because it determines how much room for error remains.

Management's message for the coming year is fairly clear: expand the customer base, keep broadening product and service exposure, continue using Chinese subcontractors where relevant, strengthen the defense vertical, and pursue new projects in auto and medical. The company also points to the Kiryat Shmona expansion and ongoing efforts to increase productive capacity. The issue is not the direction. It is the proof base. As of year-end 2025, defense is still small, auto is down, and revenue outside Israel has weakened.

That means the next year should be read through four concrete checkpoints. First, does auto stop shrinking. Second, does revenue outside Israel stop sliding, or at least does FX stop working against the group. Third, does defense move from a good but small growth pocket into something that visibly changes the top line. Fourth, does the payout pace leave a wider cash cushion inside the system.

What the market may miss on first read is that no bank debt is not the end of the story. In fact, because the balance sheet looks so clean, it is easy to under-read the weaker fourth quarter, the FX hit to financing, and the thin parent-level cash cushion. The positive side is that even if 2026 does not start with a clear rebound, Rimoni still has enough operating quality to avoid classic balance-sheet stress. The heavier side is that if the company keeps distributing at the current pace without cleaner growth, it narrows its own margin for error.

Risks

FX risk is real, and it already showed up in the numbers. The company states explicitly that shekel depreciation against the dollar and the euro helps results, and its sensitivity table quantifies a 5% move at roughly NIS 1.9 million on the dollar and about NIS 0.16 million on the euro before tax. In 2025, that exposure worked in the wrong direction.

The operating risk is not just demand risk. It is also supply-chain risk. Plastics do not show broad supplier dependence, but the company does flag one real operational dependency: Polplast in Poland, the subcontractor used for auto-related plastic products, which cannot be replaced quickly without requalification and customer approvals. In addition, one major supplier accounted for 14% of 2025 purchases in a transaction with a controlling shareholder. That does not automatically mean a problem, but it does mean procurement is not fully anonymous or frictionless.

Customer concentration exists, even if it is not extreme. Customer A accounted for NIS 21.2 million of revenue, about 12% of total sales, and two large customers represented NIS 12.9 million of receivables at year-end. This is not existential concentration, but it is material enough to matter, especially when part of the weakness is already tied to auto and export demand.

Labor remains a real bottleneck. The company says plastics utilization is around 70%, constrained by labor availability. So even if demand improves, the group still needs to retain and recruit enough skilled workers to convert capacity into revenue.

The security backdrop remains an open external risk, even if it had no material effect through the reporting date. The company says there was no material impact on operations, assets, or raw-material availability through the date of the report, but it also states that it cannot yet assess the full consequences of a prolonged escalation, especially through energy, shipping, raw materials, workforce, and overseas customers. That is not sitting on the balance sheet today, but it absolutely sits inside the thesis.

Conclusions

Rimoni exits 2025 as a profitable industrial business with a real manufacturing base and a balance sheet free of bank debt. That supports the thesis. The main blocker now is not leverage or going-concern stress. It is the gap between a still-resilient operating core and a distribution policy that leaves less cushion than a first reading suggests. Over the short to medium term, the market will mainly test whether export and auto softness was temporary and whether the company can keep more cash inside the system without undermining its shareholder message.

Current thesis in one line: Rimoni remains a capable, profitable precision manufacturer, but 2025 showed that the stock is no longer judged only on operating quality. It is also judged on payout discipline and the quality of its currency and auto exposure.

What changed versus 2024? It was still possible to read the company mainly as a stable industrial business with a very comfortable balance sheet. After 2025, it has to be read through the question of how much of that value is actually left in accessible cash after the dividend.

The strongest counter-thesis is that concern about the cash cushion is overstated: the group still generates more than NIS 40 million of operating cash, has no bank debt, and the plastics segment remains highly profitable, so management could always moderate the payout if needed. That is an intelligent objection. The problem is that it assumes the FX and auto drag is temporary and that there will be no further supply-chain or demand shocks.

What could change market interpretation over the short to medium term? A clear rebound from the weak fourth quarter, visible scaling in defense, stabilization in revenue outside Israel, or on the negative side, another period in which distribution continues to outrun cash retention. That is the real watchlist.

Why does this matter? Because Rimoni is no longer being screened only on whether it can manufacture well. It is being screened on whether it can turn that operating quality into cash that actually remains inside the system long enough to preserve flexibility.

What must happen over the next 2 to 4 quarters for the thesis to strengthen? Auto needs to stabilize, defense and technical need to keep growing, the quarterly run-rate needs to improve versus Q4, and the payout policy needs to stop running ahead of all-in cash generation. What would weaken the thesis? More export erosion, more FX pressure, and continued shrinkage of the cash cushion despite the absence of bank debt.